Depression does not appear to directly cause cancer. The largest studies to date, pooling data from over 300,000 people, have found no clear link between depression and overall cancer risk once lifestyle factors like smoking, drinking, and body weight are accounted for. But the relationship is more complicated than a simple yes or no. Depression changes behavior, alters immune function, and may worsen outcomes for people who already have cancer.
What the Largest Studies Actually Show
A major meta-analysis combining 18 cohorts and nearly 26,000 cancer cases found no association between depression and overall cancer, breast cancer, prostate cancer, or colorectal cancer. The one exception was lung cancer and other smoking-related cancers, where people with depression had a modestly higher risk. But even that link shrank considerably after adjusting for smoking, alcohol use, and BMI.
A separate study of more than 235,000 patients did find that people with depression had an 18% higher overall risk of being diagnosed with cancer. Lung cancer showed the largest gap (39% higher risk), followed by gastrointestinal cancers (30%), breast cancer (23%), and urinary cancers (23%). Prostate cancer showed no difference at all. These numbers, however, don’t fully separate the effect of depression itself from the behaviors that often accompany it.
Lifestyle Habits Explain Much of the Link
Depression makes people more likely to smoke, drink heavily, eat poorly, and exercise less. These are all established cancer risk factors on their own, and they appear to account for a large share of the statistical connection between depression and cancer. In one large cohort study, smoking alone explained 27% of the apparent link between depression and lung cancer in women and 17% of the link between depression and all cancers in men. Alcohol added a small additional contribution.
When researchers in the PSY-CA consortium adjusted for these behavioral risk factors, the elevated cancer risk associated with depression dropped substantially. Hazard ratios that ranged from 1.06 to 1.60 before adjustment fell to 1.04 to 1.23 afterward, meaning most of the “excess” cancer risk wasn’t from depression itself but from the habits that tend to go along with it.
How Depression Affects the Immune System
Even though the direct cancer-causing link is weak, depression does produce real biological changes that could, in theory, create a more hospitable environment for tumors. People with depression tend to have elevated levels of inflammatory signaling molecules. Their bodies also overproduce the stress hormone cortisol through chronic activation of the brain’s stress-response system.
These changes can suppress the immune cells that normally patrol the body for abnormal cells, including natural killer cells, macrophages, and other frontline defenders. Depression also disrupts the balance of brain chemicals like serotonin, and low serotonin levels are linked to further increases in inflammation. This creates a cycle: low serotonin fuels inflammation, and inflammation worsens depression. Whether this cycle is strong enough to meaningfully increase cancer risk in humans, rather than just in lab models, remains unproven.
Sometimes Cancer Causes the Depression
One important wrinkle in the data is reverse causality. In some cases, what looks like “depression leading to cancer” is actually an undiagnosed cancer producing depressive symptoms months before it’s detected. Pancreatic cancer is the best-documented example. Between 10% and 20% of pancreatic cancer patients develop depression in the months before their cancer diagnosis, independently of weight loss or other physical symptoms. Researchers believe the tumor itself triggers this through systemic inflammation and changes in brain chemistry.
This means some studies that appear to show depression increasing cancer risk may partly be capturing cases where a hidden cancer was already affecting mood. It’s a reminder that new, unexplained depression, particularly in older adults, sometimes deserves a closer medical look.
Depression’s Real Danger: Worse Cancer Outcomes
Where depression most clearly matters is not in causing cancer but in worsening survival once cancer is diagnosed. A 2025 meta-analysis of 65 studies found that depression increased cancer-specific mortality by 23% to 83%, depending on the cancer type. Colorectal cancer patients with depression had an 83% higher death rate. Prostate cancer patients with depression had a 74% higher rate, lung cancer patients 59% higher, and breast cancer patients 23% higher. Across mixed cancer types, the increase averaged 38%.
Several factors likely drive this. People with depression are less likely to keep up with screening. In postmenopausal women, those with depressive symptoms were less likely to get screened for breast cancer compared to women without depression. Depression also makes it harder to follow treatment plans, attend follow-up appointments, and maintain the nutrition and activity levels that support recovery. The immune suppression and chronic inflammation described earlier may also play a role in allowing existing tumors to grow faster.
What About Antidepressants?
Early research raised concerns that common antidepressants might increase cancer risk, but more recent and larger studies have not supported that worry. In fact, some evidence points in the opposite direction. A nationwide cohort study found that certain antidepressants were associated with a reduced risk of bladder cancer by 27% to 40%, depending on the specific medication. Other population-based studies have found similar protective associations for liver and ovarian cancers, and lab studies have shown that these medications can trigger cancer cell death in cell cultures. The overall picture is reassuring: treating depression does not appear to raise cancer risk and may offer modest protective effects, though more research is needed to confirm this.
The Bottom Line on Risk
If you’re living with depression and worried about cancer, the evidence should be somewhat reassuring. Depression is not an established cause of cancer the way smoking or heavy alcohol use are. The statistical links that do appear are largely explained by lifestyle factors that are modifiable. The real concern is that untreated depression can lead to worse outcomes if cancer does develop, through delayed screening, reduced treatment adherence, and biological changes that may help tumors progress. Treating depression effectively addresses many of these risks at once.